03.22.24 -- When In The Product's Life Cycle Does Continuous Manufacturing Make Sense?

Businesses adopt outsourcing to Asia as a pivotal strategy. While this entails both benefits and drawbacks, explore why teams should first necessitate careful consideration before making a decision.

Explore different pollution-contributing factors in biochemical manufacturing, spatial considerations when comparing disposable to traditional systems, and current environmental-based initiatives.

Quality experts are facing the challenge of rethinking their roles and redesigning the quality systems of their pharmaceutical companies to be based on the concepts of data quality.

Discover how, in combination with artificial intelligence, augmented reality, robotics, and digital twins, biopharma 4.0 is changing legacy concepts from the ground up.

Find out how a strategic partnership with a used equipment dealer can provide guidance through the process of a merger or acquisition of manufacturing facilities and simplify equipment removal and sales.

Learn about a solution for streamlining workflow in novel biologics while collecting quality data by combining single-use microbioreactors with advanced automation and analytical platforms.

Antibody-drug conjugates' manufacturing supply chain contains five different technologies with specific asset needs: monoclonal antibody, cytotoxic payload, linker, bioconjugation, and fill/finish.

Achieving optimized, scalable suspension processes for adeno-associated virus (AAV)-based therapeutics comes with a number of technical and business challenges.

Learn more about oligo workflows and solutions for oligonucleotide process development, from scalable oligo synthesis to cleavage and deprotection, purification, and buffer exchange.